retatrutide cardiovascular side effects cardiac 💉𝗥𝗲𝘁𝗮𝘁𝗿𝘂𝘁𝗶𝗱𝗲'𝘀 𝗨𝗻𝗲𝘅𝗽𝗲𝗰𝘁𝗲𝗱 𝗦𝗶𝗱𝗲 𝗘𝗳𝗳𝗲𝗰𝘁: 𝗪𝗵𝗮𝘁 𝗬𝗼𝘂 𝗦𝗵𝗼𝘂𝗹𝗱 𝗞𝗻𝗼𝘄 𝗥𝗲𝘁𝗮𝘁𝗿𝘂𝘁𝗶𝗱𝗲: a new triple-agonist weight loss drug that is STILL IN CLINICAL TRIALS, is showing GLP-1 Agonists in Cardiovascular Diseases:

Refer to the Community Needs Assessment Guidance and associated webinars for additional specifics (link below)

Future Market Landscape: Small molecules act as GLP-1 popularizers for first-line basic treatment, while peptide drugs lead as pioneers in high-efficacy therapies and innovative indications

However, the same study also found lower/more attenuated post-prandial responses of GLP-1 and GIP [106], consistent with findings from a subsequent study that found worsening OSA was associated with reduced GLP-1 levels [107]

However, if they persist or you experience severe side effects, consult your healthcare provider before taking the next dosage of tirzepatide

Huang, X., Gu, X., Zhang, G